Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance Evaluation of the Seraph® 100 Microbind® Affinity Blood Filter for Reducing Bacteremia in Patients on Hemodialysis

NCT02914132 is registered in ClinicalTrials.gov with ExThera Medical Corporation as lead sponsor.

NCT NCT02914132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02914132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance Evaluation of the Seraph® 100 Microbind® Affinity Blood Filter for Reducing Bacteremia in Patients on Hemodialysis
Lead sponsor
ExThera Medical Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
June 7, 2018
Enrollment
15 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, bacterial infection